ATMPs – Prepare for Successful Access in a Changing Environment

Published on January 19, 2023

In this article, we discuss the expected impact of current trends and healthcare system initiatives on advanced therapy medicinal products (ATMP) Pricing & Market Access and highlight the resulting opportunities and challenges for manufacturers. Read our recommendations on how to best prepare for successful access here.

We have entered a new era of personalized medicine, where one-time treatments can lead to complete eradication of diseases. Advanced therapy medicinal products (ATMPs), encompassing gene therapies, somatic cell therapies, and tissue-engineered products, have different characteristics compared to most existing marketed therapies. They come with a number of access challenges such as single, upfront payments, launching with limited data, and durable/curative claims not proven at the time of launch.

To address the challenges associated with ATMPs, as well as other non-standard medicines, many European markets are undertaking…

Continue reading on website
Other news

How Upstart Carmakers Can Discover Their European Target Customers

January 19, 2023
How can international automotive companies convince potential customers to consider their brands? In part two of our How Emerging Markets Can Succeed in Europe series, we explain the importance of understanding target consumers and how to overcome the biggest barriers to entry.Knowing your target customers and how to reach them is a quintessential step of a market entry strategy, especially when a

Embracing the Change: Strategizing on Volume-based Procurement in China

January 19, 2023
Volume-based procurement (VoBP or VBP) started its rollout in China in 2018, featuring stiff competition and steep price cuts for mature drugs. More recently, VoBP has been broadening in scope and accelerating in pace. To make the best out of the inevitable, major pharmaceutical firms will need to strategize and prepare for upcoming rounds on both national and regional levels.Volume-based procurem